NLRP3 and COVID-19: This compound prevented SARS‐CoV‐2 S1‐induced NLRP3 inflammasome stimulation, reducing the production of pro‐inflammatory mediators and subsequently mitigating COVID‐19‐associated neuroinflammation [95].